GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accumulated other comprehensive income (loss)

Alto Neuroscience (Alto Neuroscience) Accumulated other comprehensive income (loss) : $-0.08 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Alto Neuroscience's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $-0.08 Mil.

Alto Neuroscience's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 ($-0.09 Mil) to Dec. 2023 ($-0.08 Mil) but then declined from Dec. 2023 ($-0.08 Mil) to Mar. 2024 ($-0.08 Mil).

Alto Neuroscience's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-0.02 Mil) to Dec. 2022 ($-0.05 Mil) and declined from Dec. 2022 ($-0.05 Mil) to Dec. 2023 ($-0.08 Mil).

Alto Neuroscience Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Alto Neuroscience's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Accumulated other comprehensive income (loss) Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
-0.02 -0.05 -0.08

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial -0.05 - -0.09 -0.08 -0.08

Alto Neuroscience Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Alto Neuroscience Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024